- トップ
- 研究業績
- Kojima M, Nishikii H, Takizawa J, Aoki S, Noguchi M, Chiba S, Ando K, Nakamura N. MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: multi-center analysis of Japanese patients with diffuse large B-cell lymphoma. Leuk Lymphoma 54(10):2149-2154, Oct, 2013 (doi:10.3109/10428194.2013.771398)
Kojima M, Nishikii H, Takizawa J, Aoki S, Noguchi M, Chiba S, Ando K, Nakamura N. MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: multi-center analysis of Japanese patients with diffuse large B-cell lymphoma. Leuk Lymphoma 54(10):2149-2154, Oct, 2013 (doi:10.3109/10428194.2013.771398)
2014/12/08
- 研究業績
- Kojima M, Nishikii H, Takizawa J, Aoki S, Noguchi M, Chiba S, Ando K, Nakamura N. MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: multi-center analysis of Japanese patients with diffuse large B-cell lymphoma. Leuk Lymphoma 54(10):2149-2154, Oct, 2013 (doi:10.3109/10428194.2013.771398)
« Sakamoto K, Nakasone H, Tsurumi S, Sasaki K, Mitani K, Kida M, Hangai... | Sakamoto T, Obara N, Kurita N, Sakata-Yanagimoto M, Nishikii H, Yok... »
